Efficacy of adequate empiric antibiotic therapy in ventilator-associated pneumonia (VAP): Impact of the baseline severity of patients

被引：0
|
作者：
Clec'h, C
Timsir, JF
Adrie, C
Alberti, C
Cheval, C
Delassence, A
Thuong, M
Troche, G
Moine, P
Cohen, Y
机构：
[1] Hop Avicenne, Serv Reanimat, F-93009 Bobigny, France
[2] Outcome Rea, Serv Reanimat, Paris, France
来源：
INTENSIVE CARE MEDICINE | 2001年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
193
引用
收藏
页码：S184 / S184
页数：1
相关论文
共 50 条
  • [31] Safety of targeted antibiotic therapy for ventilator associated pneumonia (VAP).
    Joffe, Ari R.
    Muscedere, J.
    Heyland, D. K.
    Marshall, J.
    Su, Y.
    CRITICAL CARE MEDICINE, 2006, 34 (12) : A102 - A102
  • [32] EFFICACY OF IMPLEMENTING A CARE BUNDLE TO PREVENT VENTILATOR-ASSOCIATED PNEUMONIA (VAP)
    Socias Mir, A.
    Gutierrez Madronal, L.
    Barcelo Planas, J.
    Rialp Cervera, G.
    Ibanez Lucia, P.
    INTENSIVE CARE MEDICINE, 2012, 38 : S212 - S213
  • [33] Efficacy of antibiotic prophylaxis against ventilator-associated pneumonia
    Mirtalaei, N.
    Farazi, A.
    Monfared, M. Ebrahimi
    Jokar, A.
    JOURNAL OF HOSPITAL INFECTION, 2019, 101 (03) : 272 - 275
  • [34] Reduction in inadequate empiric antibiotic therapy for ventilator-associated pneumonia: Impact of a unit-specific treatment pathway - Discussion
    Cheadle, William G.
    Magnotti, Louis J.
    Maxwell, Robert
    AMERICAN SURGEON, 2008, 74 (06) : 522 - 523
  • [35] The Impact Of Implementing Multifaceted Interventions On The Prevention Of Ventilator-Associated Pneumonia (vap)
    Khan, R.
    Obbed, S. O.
    Al-Attas, K.
    Marini, A.
    Mundekkadan, S.
    Zehri, K.
    Tannous, J.
    Musned, A.
    Mannion, D.
    Zayer, S. A.
    Balkhy, H.
    Arabi, Y. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [36] Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia
    Nicasio, Anthony M.
    Eagye, Kathryn J.
    Nicolau, David P.
    Shore, Eric
    Palter, Marc
    Pepe, Judith
    Kuti, Joseph L.
    JOURNAL OF CRITICAL CARE, 2010, 25 (01) : 69 - 77
  • [37] EVALUATION OF VENTILATOR-ASSOCIATED PNEUMONIA EMPIRIC ANTIBIOTIC TREATMENT IN INTENSIVE CARE UNITS
    Cervantes, Alexandra
    Cardin, Daniel
    Daniels, Lindsay
    CRITICAL CARE MEDICINE, 2019, 47
  • [38] IMPLICATION OF INAPPROPRIATE EMPIRICAL ANTIBIOTIC THERAPY (IEAT) OF VENTILATOR-ASSOCIATED PNEUMONIA (VAP) IN A RURAL TRAUMA POPULATION
    Furnari, Graziella
    CRITICAL CARE MEDICINE, 2012, 40 (12) : U265 - U265
  • [39] Optimising the duration of antibiotic therapy for ventilator-associated pneumonia
    Chastre, J.
    Luyt, C. E.
    EUROPEAN RESPIRATORY REVIEW, 2007, 16 (103): : 40 - 44
  • [40] The impact of changes in antimicrobial therapy on patients with ventilator-associated pneumonia
    Kawabata, M
    de Corla-Souza, A
    Niederman, MS
    CHEST, 2003, 124 (04) : 79S - 79S
12345